InSphero CEO Advancing NAMs & Organs-on-Chips in Drug Discovery
ch
Jan Lichtenberg is an InSphero CEO Advancing NAMs & Organs-on-Chips in Drug Discovery, ranked #2 in Health & Medicine (Pharma & Biotech) (Top 4%).
Last updated
Jan Lichtenberg is the CEO of InSphero and a board member at the Society of Laboratory Automation and Screening. He specializes in 3D cell culture and organ-on-a-chip technology for pharmaceutical research, collaborating with top pharma companies to accelerate drug discovery and reduce animal testing. Based in Zurich, Switzerland, he is also a mentor for startups in the biotechnology and medical-device industry.
Turning great science into robust technology, and technology into useful and valuable products.
Favikon helps you find the right creators, analyze them in depth, reach out at scale, and track what works.
Switzerland
